You’re in the best of hands.
From the perspective of patient care, research innovations, training new cancer specialists, and providing service to the state of Iowa, leadership for Holden Comprehensive Cancer Center has never been stronger.
The physicians and researchers who direct Holden’s activities are prepared for their role as leaders because they also are:
- Principal investigators in groundbreaking cancer research
- Experts at the national and international level shaping priorities for cancer research and care
- Communicators about cancer successes and challenges for local and national audiences
- Mentors for young doctors and researchers who will carry the Holden legacy into the future
- Family members who have themselves been touched by cancer
New Director
Mark Burkard, MD, PhD began as director of University of Iowa Health Care Holden Comprehensive Cancer Center on October 1, 2024. Burkard also serves as a professor in the Department of Internal Medicine in the Division of Hematology, Oncology, and Blood and Marrow Transplantation in the Carver College of Medicine. Burkard’s research is focused on understanding the drivers of genomic changes in breast cancer and developing precision treatments–such as targeted drugs, chemotherapy, and immunotherapies.
Holden’s Leadership Team
Mark E. Burkard, MD, PhD
C.E. Block Chair of Cancer Research
Professor
Jon C. Houtman, PhD
Professor
George J. Weiner, MD
Professor
Gail A. Bishop, PhD
Professor
Tina R. Devery, MHA
Adam J. Dupuy, PhD
Associate Professor
Jessica C. Sieren, PhD
Associate Professor
Umar Farooq, MD
Clinical Professor
Natoshia M. Askelson, MPH, PhD
Associate Professor
Elizabeth Chrischilles, PhD
Professor
Tara Graff, DO, MS
Scott Hansen
